1,3-Dibromo-5-fluorobenzene | CAS:1435-51-4

We serve 1,3-Dibromo-5-fluorobenzene CAS:1435-51-4 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
1,3-Dibromo-5-fluorobenzene

Chemical Name:1,3-Dibromo-5-fluorobenzene
CAS.NO:1435-51-4
Synonyms:1,3-Dibromo-5-fluorobenzene
1-fluoro-3,5-dibromobenzene
3,5-Dibromo-1-fluorobenzene
 
Physical and Chemical Properties:
Density 2.0±0.1 g/cm3
Boiling Point 204.6±0.0 °C at 760 mmHg
Molecular Formula C6H3Br2F
Molecular Weight 253.894
Flash Point 82.5±21.8 °C
Vapour Pressure 0.4±0.3 mmHg at 25°C
Index of Refraction 1.575
 
Specification:
Appearance:Light yellow transparent liquid
Assay:≥99.0%
Moisture:≤0.5%
 
Packing:200 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Organic synthesis.



Contact us for information like 1,3-Dibromo-5-fluorobenzene chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,3,5-Dibromo-1-fluorobenzene physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1,3-Dibromo-5-fluorobenzene Use and application,1-fluoro-3,5-dibromobenzene technical grade,usp/ep/jp grade.


Related News: Chinese President Xi Jinping vowed to tackle the spread of the virus, saying: “People’s lives and health should be given top priority and the spread of the outbreak should be resolutely curbed.”3-Piperazinylpropylmethyldimethoxysilane manufacturer Catalent, a global leader in clinical supply services, recently announced the launch of its new CTSuccessTM clinical trial planning service, designed to support trial sponsors with earlier, more proactive and robust clinical supply chain planning, and reduce the risk of delays and budget overspend common to clinical trials as they progress.1,3-dimethyl-6-[2-(p-toluenesulfonyloxy)ethylamino)-2,4(1H,3H)-pyrimidinedione supplier Only when the drug substance is processed into a pharmaceutical preparation can it become a drug for clinical application.2-Chloro-4-fluoro-1-iodobenzene vendor Britons being brought from Wuhan to the UK are being placed in quarantine at Arrowe Park Hospital in the Wirral, northwest England, Raab said.In recent years, there has been a relatively concentrated concentration of intermediate companies listed on the capital market. Most of the fund-raising projects are aimed at breaking through the bottleneck of production capacity to meet growing demand, and the entire industry has shown a vigorous development momentum.